XML 50 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)
In Millions, unless otherwise specified
 9 Months Ended
Sep. 06, 2014
Sep. 07, 2013
Operating Activities    
Net income $ 5,232 $ 5,033
Depreciation and amortization 1,794 1,815
Stock-based compensation expense 207 219
Business Combination, Integration Related Costs 0 9
Cash payments for merger and integration charges 0 (21)
Restructuring and impairment charges 258 37
Payments for Restructuring (169) (100)
Payments for Restructuring and Other Charges 0 (26)
Non-cash foreign exchange loss related to Venezuela currency devaluation 0 111
Excess tax benefits from share-based payment arrangements (86) (94)
Pension and retiree medical plan expenses 368 462
Pension and retiree medical plan contributions (196) (208)
Deferred income taxes and other tax charges and credits (8) (66)
Change in accounts and notes receivable (1,582) (1,262)
Change in inventories (481) (337)
Change in prepaid expenses and other current assets (18) (156)
Change in accounts payable and other current liabilities 537 734
Change in income taxes payable 1,115 811
Other, net (278) (299)
Net Cash Provided by Operating Activities 6,693 6,662
Investing Activities    
Capital spending (1,540) (1,497)
Sales of property, plant and equipment 60 51
Cash payments related to the transaction with Tingyi 0 (3)
Acquisitions and investments in noncontrolled affiliates (81) (82)
Divestitures 186 174
Payments for (Proceeds from) Short-term investments - More Than Three Months (5,423)   
More than three months – purchases 117 (8)
Other investing, net 3 (13)
Net Cash Used for Investing Activities (6,678) (1,378)
Financing Activities    
Proceeds from issuances of long-term debt 3,364 4,185
Payments of long-term debt (2,186) (2,954)
Short-term borrowings, by original maturity    
More than three months – proceeds 32 2
More than three months – payments (10) (476)
Three months or less, net 2,117 662
Cash dividends paid (2,745) (2,558)
Share repurchases – common (3,207) (2,041)
Share repurchases – preferred (7) (5)
Proceeds from exercises of stock options 561 991
Excess tax benefits from share-based payment arrangements 86 94
Acquisition of noncontrolling interests 0 (20)
Other financing (32) (15)
Net Cash Used for Financing Activities (2,027) (2,135)
Effect of exchange rate changes on cash and cash equivalents (81) (242)
Net (Decrease)/Increase in Cash and Cash Equivalents (2,093) 2,907
Cash and Cash Equivalents, Beginning of Year 9,375 6,297
Cash and Cash Equivalents, End of Period $ 7,282 $ 9,204